// CKD - chronic kidney disease
// modified for the JAMIA study
// version 3 -- changed antiplatelets to aspirin
// version 2 -- removed the decision step for anamia and replaced it with the hemoglobin testing
// version 1 -- consistent with the text


digraph case_2_ckd_exp {
// newrank=true;
ranksep=0.25;

node [shape=box, style=filled, fillcolor=deepskyblue, fontname=calibri, fontsize=10];
edge [fontname=calibri, fontsize=9];

// Start and stop
start [label="CKD", shape=oval, style=filled, fillcolor=lightgray];
// end [shape=oval label="CKD - End", fillcolor=red]

// Actions
a_phosphate_binders [label=<Phosphate binders<br/><i>duration: lifetime</i>>];
// a_cvd_risk_management [label="CVD risk management"];
a_esa [label=<ESA <br/> <i>duration: lifetime</i>>];
a_iron_therapy [label=<Oral iron therapy <br/> <i>duration: 8 weeks</i>>];

subgraph cluster0 {
    label="HTN prevention";
    fontname=calibri; fontsize=9; style=dotted;
    a_ace_inhibitor [label=<ACE inhibitor <br/> <i>duration: lifetime</i>>];
}

subgraph cluster1 {
    label="CVD prevention";
    fontname=calibri; fontsize=9; style=dotted;
    a_aspirin [label=<Low dose aspirin <br/> <i>duration: lifetime</i>>];
    a_anticoagulant [label=<Warfarin or DOAC <br/> <i>duration: lifetime</i>>, fillcolor=orange];
    a_lifestyle_management [label=<Lifestyle management for CVD <br/> <i>duration: lifetime</i>>];
    a1 [shape=trapezium, height=0.3, width=0.4, fixedsize=true, fillcolor=gold, label=<alt>];
    a2 [shape=trapezium, height=0.3, width=0.4, fixedsize=true, fillcolor=gold, label=<alt>];
}

// Decisions
d_egfr [shape=diamond, fillcolor=darkorange, label="eGFR level?"];
// d_anemia [shape=diamond, fillcolor=darkorange, label="Anemia \n present?"];

d_hemoglobin_level [shape=diamond, fillcolor=darkorange, label="Hemoglobin \n level?"];
d_metabolic_abnormality_present [shape=diamond, fillcolor=darkorange, label="Metabolic \n abnormality \npresent?"];
d_ferritin_level [shape=diamond, fillcolor=darkorange, label="Ferritin \n level?"];

// Parallel gateways
p1 [shape=hexagon, height=0.3, width=0.4, fixedsize=true, fillcolor=gold, label=<para>];
p2 [shape=hexagon, height=0.3, width=0.4, fixedsize=true, fillcolor=gold, label=<para>];
p3 [shape=hexagon, height=0.3, width=0.4, fixedsize=true, fillcolor=gold, label=<para>];
p4 [shape=hexagon, height=0.3, width=0.4, fixedsize=true, fillcolor=gold, label=<para>];
p_end [shape=hexagon, height=0.3, width=0.4, fixedsize=true, fillcolor=gold, label=<para>];

// Arcs
start -> d_egfr;
// d_egfr -> d_anemia [label="< 60"];
d_egfr -> d_hemoglobin_level [label="< 60"];
d_egfr -> p2 [label=">= 60"];

// p1 -> p2;
// p1 -> d_anemia;
// p1 -> d_metabolic_abnormality_present;

// d_anemia -> d_metabolic_abnormality_present [label="no"];
// d_anemia -> d_hemoglobin_level [label="yes"];

d_hemoglobin_level -> p3 [label="< 100"];
p3 -> a_esa, d_ferritin_level;
d_hemoglobin_level -> d_ferritin_level [label = ">= 100"];

d_ferritin_level -> p4 [label="< 100"];
p4 -> a_iron_therapy, d_metabolic_abnormality_present
d_ferritin_level -> d_metabolic_abnormality_present [label=">= 100"];

d_metabolic_abnormality_present -> p1 [label="yes"];
p1 -> a_phosphate_binders;
p1 -> p2;

d_metabolic_abnormality_present -> p2 [label="no"];

p2 -> a1, a_lifestyle_management, a_ace_inhibitor;
a1 -> a_aspirin, a_anticoagulant -> a2;

a_esa, a_iron_therapy, a_ace_inhibitor, a_lifestyle_management, a2, a_phosphate_binders -> p_end;

a_esa -> a_iron_therapy [style=invis];
}